Literature DB >> 1084929

Relationship of lymphocytotoxic antibodies to lymphopenia and parameters of disease activity in systemic lupus erythematosus.

P D Utsinger.   

Abstract

Peripheral blood lymphocyte subpopulations determined in 40 patients with systemic lupus erythematosus, revealed significant lymphopenia in comparison to normal controls. The lymphopenia was caused by decreases in the absolute numbers of both T cells and surface immunoglobulin bearing (SIg) cells. There were significant percentage decreases in T cells and normal percentages of SIg cells, resulting in an increased percentage of "null" cells. The lymphopenia was significantly greater in patients considered to have active disease on the basis of clinical parameters, and was strongly correlated with lymphocytotoxic antibodies, DNA antibodies, and hypocomplementemia. The lymphocytotoxic antibodies were reactive with both T and B lymphocytes from normal and ill donors, human organs, and various lymphoblastoid cell lines. In 30 patients who were followed for up to 22 months, the lymphopenia was clearly seen to develop during, but not before, periods of clinical disease activity, independent of changes in therapy.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1084929

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  5 in total

1.  Serum lymphocytotoxic activity in leprosy.

Authors:  F N Rasheed; M Locniskar; D J McCloskey; R S Hasan; T J Chiang; P Rose; R de Soldenhoff; H Festenstein; K P McAdam
Journal:  Clin Exp Immunol       Date:  1989-06       Impact factor: 4.330

2.  Lymphocytotoxic antibodies in systemic lupus erythematosus: their clinical significance.

Authors:  B Bresnihan; R R Grigor; G R Hughes
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1979

3.  Human blood L lymphocytes in patients with active systemic lupus erythematosus, rheumatoid arthritis and scleroderma: a comparison with T and B cells.

Authors:  D A Horwitz; K Juul-Nielsen
Journal:  Clin Exp Immunol       Date:  1977-12       Impact factor: 4.330

4.  Phytohemagglutinin response in systemic lupus erythematosus. Reconstitution experiments using highly purified lymphocyte subpopulations and monocytes.

Authors:  P D Utsinger; W J Yount
Journal:  J Clin Invest       Date:  1977-09       Impact factor: 14.808

5.  Antibodies to early EBV, CMV, and HHV6 antigens in systemic lupus erythematosus patients.

Authors:  N S Rasmussen; A H Draborg; C T Nielsen; S Jacobsen; G Houen
Journal:  Scand J Rheumatol       Date:  2015-01-06       Impact factor: 3.641

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.